Bipartisan Bill H.R. 7391 Would Exempt FQHCs from 340B Rebate Model — 35 Cosponsors
Reps. Auchincloss (D-MA) and Bergman (R-MI) introduced the Community Health Center Drug Pricing Protection Act to exempt FQHCs from HRSA's 340B Rebate Model Pilot Program. The bill mandates upfront ceiling-price purchasing — no post-purchase reconciliation. Currently has 35 cosponsors. HRSA's RFI on 340B rebates has comments due April 20, 2026. FQHCs account for 1% of healthcare spending but treat 10% of Americans.
Key takeaways
- Bipartisan bill H.R. 7391 would exempt FQHCs from HRSA's 340B Rebate Model Pilot Program
- Currently has 35 cosponsors — mandates upfront ceiling-price purchasing (no post-purchase reconciliation)
- HRSA's RFI on 340B rebates has comments due April 20, 2026
- FQHCs account for 1% of healthcare spending but treat 10% of Americans
- Action: Submit comments on HRSA RFI before April 20 deadline
Primary source
U.S. House of RepresentativesFQHC Talent. (2026, February 10). Bipartisan Bill H.R. 7391 Would Exempt FQHCs from 340B Rebate Model — 35 Cosponsors. Primary source: U.S. House of Representatives. Retrieved April 28, 2026, from https://www.fqhctalent.com/intel/hr-7391-340b-fqhc-protection-act
More in Legislation
Jun 1
CMS Interim Final Rule on Medicaid Work Requirements Due June 1 — Will Define Exemptions, Reporting, and Enforcement
Apr 20
HRSA 340B Rebate Model RFI — Comment Deadline April 20
Apr 20
HRSA 340B Rebate Model RFI: Comment Deadline April 20 — Possible Expansion to All IRA Drugs
Apr 20
SB 1422 Committee Hearing April 20 — Bill to Restore Full Medi-Cal for Undocumented Adults Faces Critical Gate